Land- and water-based aerobic exercise program on health-related outcomes in breast cancer survivors (WaterMama): study protocol for a randomized clinical trial

dc.contributor.authorLima Alberton, Cristine
dc.contributor.authorSiqueira Andrade, Luana
dc.contributor.authorBotelho Xavier, Bruno Ezequiel
dc.contributor.authorGuesser Pinheiro, Victor Hugo
dc.contributor.authorCuesta-Vargas, Antonio
dc.contributor.authorSantana Pinto, Stephanie
dc.date.accessioned2024-12-17T12:21:24Z
dc.date.available2024-12-17T12:21:24Z
dc.date.issued2024-08-13
dc.departamentoFisioterapia
dc.description.abstractBackground: Breast cancer is a prevalent form of cancer among women worldwide, often accompanied by physical and psychological side effects due to the disease and the treatment's aggressiveness. Regular physical exercise has emerged as a non-pharmacological approach to improve the quality of life of breast cancer survivors. We herein report the protocol of the WaterMama Study, which aims to evaluate the effects of land- or water-based aerobic exercise programs, compared to a health education program, on cancer-related fatigue and other health-related outcomes in breast cancer survivors. Methods: The WaterMama trial is a randomized, single-blinded, three-arm, parallel, superiority trial. We aim to recruit 48 women ≥ 18 years of age who have completed primary treatment for stage I-III breast cancer. Participants are randomly allocated in a 1:1:1 ratio to 12-week interventions of aerobic exercise training programs either in the aquatic or land environment (two weekly 45-min sessions) plus health education (a weekly 45-min session), or an active-control group receiving health education alone (a weekly 45-min session). The primary outcome is cancer-related fatigue, and the secondary outcomes include cardiorespiratory fitness, muscular performance, muscle morphology, functional capacity, mental health, cognitive function, pain, and quality of life. Outcomes assessments are conducted before and after the 12-week intervention period. The analysis plan will employ an intention-to-treat approach and per protocol criteria. Discussion: Our conceptual hypothesis is that both aerobic exercise programs will positively impact primary and secondary outcomes compared to the health education group alone. Additionally, due to its multi-component nature, we expect the aquatic exercise program promote more significant effects than the land exercise program on cancer-related fatigue, muscular outcomes, and pain.es_ES
dc.identifier.citationAlberton, C.L., Andrade, L.S., Xavier, B.E.B. et al. Land- and water-based aerobic exercise program on health-related outcomes in breast cancer survivors (WaterMama): study protocol for a randomized clinical trial. Trials 25, 536 (2024). https://doi.org/10.1186/s13063-024-08389-yes_ES
dc.identifier.doi10.1186/s13063-024-08389-y
dc.identifier.urihttps://hdl.handle.net/10630/35722
dc.language.isoenges_ES
dc.publisherBMC Springer Naturees_ES
dc.rights.accessRightsopen accesses_ES
dc.subjectEjercicio físico - Uso terapéuticoes_ES
dc.subject.otherAquatic exercisees_ES
dc.subject.otherBreast neoplasmes_ES
dc.subject.otherCancer-related fatiguees_ES
dc.subject.otherCognitive functiones_ES
dc.subject.otherMental healthes_ES
dc.subject.otherPaines_ES
dc.subject.otherPhysical activityes_ES
dc.subject.otherPhysical exercisees_ES
dc.subject.otherPhysical fitnesses_ES
dc.subject.otherQuality of lifees_ES
dc.titleLand- and water-based aerobic exercise program on health-related outcomes in breast cancer survivors (WaterMama): study protocol for a randomized clinical triales_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication94126d4b-371d-4727-a252-f4182972d4b6
relation.isAuthorOfPublication.latestForDiscovery94126d4b-371d-4727-a252-f4182972d4b6

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2024 Land‑ and water‑based aerobic exercise program on health‑related outcomes in breast cancer survivors (WaterMama) study protocol for a randomized clinical trial.pdf
Size:
1.07 MB
Format:
Adobe Portable Document Format
Description:

Collections